UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

DNA‐PKc inhibition overcomes taxane resistance by promoting taxane‐induced DNA damage in prostate cancer cells

The Prostate, 2021-10, Vol.81 (14), p.1032-1048

2021

Volltextzugriff (PDF)

Role of CYP3A5 in Modulating Androgen Receptor Signaling and Its Relevance to African American Men with Prostate Cancer

Cancers, 2020-04, Vol.12 (4), p.989

2020

Volltextzugriff (PDF)

A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma

European urology oncology, 2024-08, Vol.7 (4), p.933-943

2024

Volltextzugriff (PDF)

A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors

Investigational new drugs, 2018-12, Vol.36 (6), p.1060-1071

2018

Volltextzugriff (PDF)

Neprilysin Inhibits Angiogenesis via Proteolysis of Fibroblast Growth Factor-2

The Journal of biological chemistry, 2006-11, Vol.281 (44), p.33597-33605

2006

Volltextzugriff (PDF)

Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial

Clinical cancer research, 2022-08, Vol.28 (15), p.3248-3255

2022

Volltextzugriff (PDF)

Neutral endopeptidase is a myristoylated protein

Molecular and cellular biochemistry, 2010-02, Vol.335 (1-2), p.173-180

2010

Volltextzugriff (PDF)

Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer

Clinical cancer research, 2022-06, Vol.28 (11), p.2237-2247

2022

Volltextzugriff (PDF)

The relevance of BRCA genetics to prostate cancer pathogenesis and treatment

Clinical advances in hematology & oncology, 2011-10, Vol.9 (10), p.748-755

2011

Volltextzugriff (PDF)

The HDAC6 Inhibitor Tubacin Induces Release of CD133+ Extracellular Vesicles From Cancer Cells

Journal of cellular biochemistry, 2017-12, Vol.118 (12), p.4414-4424

2017

Volltextzugriff (PDF)

Bombesin attenuates pre-mRNA splicing of glucocorticoid receptor by regulating the expression of serine-arginine protein p30c (SRp30c) in prostate cancer cells

Biochimica et biophysica acta, 2007-07, Vol.1773 (7), p.1087-1094

2007

Volltextzugriff (PDF)

Is there a role for LHRH antagonists in prostate cancer?

Oncology (Williston Park, N.Y.), 2009-06, Vol.23 (7), p.632, 635-635

Goodman, Jr, Oscar B

2009

Volltextzugriff (PDF)

Urothelial Bladder Carcinoma With Choriocarcinomatous Differentiation Presenting With a False-Positive Pregnancy Test

The American journal of the medical sciences, 2013-09, Vol.346 (3), p.256-258

2013

Volltextzugriff (PDF)

Multiple androgen response elements cooperate in androgen regulated activity of the type 1 neutral endopeptidase promoter

Molecular and cellular endocrinology, 2006-10, Vol.259 (1), p.10-21

2006

Volltextzugriff (PDF)

Interaction of prostate specific membrane antigen with clathrin and the adaptor protein complex-2

International journal of oncology, 2007-11, Vol.31 (5), p.1199-1203

2007

Volltextzugriff (PDF)

A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors

Journal of immunotherapy (1997), 2011-09, Vol.34 (7), p.556-567

2011

Volltextzugriff (PDF)

Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literature

Journal of medical case reports, 2009-09, Vol.3 (1), p.9110-9110

2009

Volltextzugriff (PDF)

Targeting DNA damage response to overcome taxane resistance

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.312-312

2018

Volltextzugriff (PDF)

Abstract B017: Role of CYP3A5 in modulating androgen receptor signaling and its relevance in African American prostate cancer patients

Cancer epidemiology, biomarkers & prevention, 2020-06, Vol.29 (6_Supplement_1), p.B017-B017

2020

Volltextzugriff (PDF)

Novel Antibody Approaches for T-Cell Lymphomas

Clinical lymphoma & myeloma, 2008-12, Vol.8, p.S193-S198

2008

Volltextzugriff (PDF)

Abstract 1311A: CYP3A5 regulation of androgen receptor signaling: Relevance in African American prostate cancer patients and its development as novel target

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1311-1311A

2019

Volltextzugriff (PDF)

Abstract B001: CYP3A5 promotes AR downstream signaling and contributes to therapeutic resistance

Cancer research (Chicago, Ill.), 2018-08, Vol.78 (16_Supplement), p.B001-B001

2018

Volltextzugriff (PDF)

Abstract 4650: Effect of prescription CYP3A inducers and inhibitors on response to anti-androgen therapy in prostate cancer

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4650-4650

2016

Volltextzugriff (PDF)

Abstract B48: Effect of concomitant CYP3A5-modulating drugs on androgen-receptor signaling in African American men undergoing androgen deprivation therapy

Cancer epidemiology, biomarkers & prevention, 2018-07, Vol.27 (7_Supplement), p.B48-B48

2018

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Aktive Filter

ThemaProstatic Neoplasms - Pathology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(63)

Publikationsform

Sprache

Englisch
(69)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

DNA‐PKc inhibition overcomes taxane resistance by promoting taxane‐induced DNA damage in prostate cancer cells

Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study

Role of CYP3A5 in Modulating Androgen Receptor Signaling and Its Relevance to African American Men with Prostate Cancer

A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma

A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors

Neprilysin Inhibits Angiogenesis via Proteolysis of Fibroblast Growth Factor-2

Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial

Neutral endopeptidase is a myristoylated protein

Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer

The relevance of BRCA genetics to prostate cancer pathogenesis and treatment

The HDAC6 Inhibitor Tubacin Induces Release of CD133+ Extracellular Vesicles From Cancer Cells

Bombesin attenuates pre-mRNA splicing of glucocorticoid receptor by regulating the expression of serine-arginine protein p30c (SRp30c) in prostate cancer cells

Is there a role for LHRH antagonists in prostate cancer?

Urothelial Bladder Carcinoma With Choriocarcinomatous Differentiation Presenting With a False-Positive Pregnancy Test

Multiple androgen response elements cooperate in androgen regulated activity of the type 1 neutral endopeptidase promoter

Interaction of prostate specific membrane antigen with clathrin and the adaptor protein complex-2

A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors

Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literature

Targeting DNA damage response to overcome taxane resistance

Abstract B017: Role of CYP3A5 in modulating androgen receptor signaling and its relevance in African American prostate cancer patients

Novel Antibody Approaches for T-Cell Lymphomas

Abstract 1311A: CYP3A5 regulation of androgen receptor signaling: Relevance in African American prostate cancer patients and its development as novel target

Abstract B001: CYP3A5 promotes AR downstream signaling and contributes to therapeutic resistance

Abstract 4650: Effect of prescription CYP3A inducers and inhibitors on response to anti-androgen therapy in prostate cancer

Abstract B48: Effect of concomitant CYP3A5-modulating drugs on androgen-receptor signaling in African American men undergoing androgen deprivation therapy

Aktive Filter

Suchergebnisse filtern